Skip to Content

Mergent, Inc. Announces Changes to the HealthShares Metabolic-Endocrine Disorders Index

NEW YORK, June 2 /PRNewswire/ -- Mergent, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange Traded Funds, today announced the following changes effective on the opening of trading on Thursday, June 5, 2008: NeuroSearch AS (Copenhagen: NEUR) will replace Sirtris Pharmaceuticals, Inc. (NASDAQ:SIRT) in the HealthShares(TM) Metabolic-Endocrine Disorders Index. Sirtris Pharmaceuticals, Inc. is being acquired by GlaxoSmithKline plc (NYSE:GSK) .

Companies included in the HealthShares(TM) Metabolic-Endocrine Disorders Index are engaged in the research, clinical development and/or commercialization of therapeutic agents for the treatment of a wide variety of metabolic-endocrine disorders including, but not limited to, diabetes, obesity, Syndrome X, growth deficiency and rare lysosomal disorders.

About Mergent

Mergent, Inc., a Xinhua Finance company (TSE Mothers: 9399; OTC ADRs: XHFNY), is the preferred provider of business and financial data on global publicly listed companies. Headquartered in Fort Mill, SC and New York City with sales offices in key North American cities, Mergent also has a strong global presence with offices in London, Shanghai, Tokyo, Toronto and Sydney. Mergent's databases contain detailed equity, debt and corporate action information on over 15,000 U.S. public companies, 20,000 non-U.S. public companies and all U.S. municipal bonds.

For more than a century, Mergent has been providing solutions to clients in the investment management, academic, research and corporate information fields. Today, that unique experience is combined with leading-edge technology to form a robust, diverse product line that operates under Mergent's umbrella. These include Mergent's Dividend Achievers Indices -- the premier benchmark for long-term returns; Ford Equity Research -- a leading independent investment research firm; Mergent Online -- a powerful web-based research portal that provides critical business information to support daily research and analysis; Mergent Manuals, Handbooks and Investment Guides; in-depth municipal and corporate fixed-income data, as well as end-of-day evaluation pricing; EventsData -- providing real-time information on corporate actions, dividend payouts, news and updates directly to client desktops. For more information, please visit and

Source: Mergent, Inc.

CONTACT: Jean Dugan, Director of Sales, Index Services of Mergent, Inc.,

Posted: June 2008